Key facts
- HeartLab’s last known valuation is $3.5M (Oct 2020).
- It has raised $3.5M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Founders Fund, Icehouse Ventures, Dylan Field, Auckland UniServices, Callaghan Innovation — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for HeartLab
- ·The full record, as it builds
Funding rounds
No funding rounds for HeartLab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HeartLab
Developer of AI-based diagnostic tools designed to help doctors diagnose and treat cardiovascular disease. The company's advanced deep learning-based tools facilitate doctors in gathering more details from an echocardiogram and automate the repetitive and time-consuming tasks involved in taking measurements from the tests, enabling doctors and clinicians to perform echocardiograms and interpret the results in very little time.
- Sector
- Healthcare
- HQ
- Auckland, New Zealand
- Founded
- 2018
- Employees
- 23
- Website
- heartlab.com/
- Ownership
- Privately Held (backing)
HeartLab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HeartLab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HeartLab in its N-PORT filings yet. We sweep new filings monthly.